C07K 14/575
Hormones
Official title: Hormones (derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin C07K14/665, e.g. corticotropin C07K14/695)
C07K14/575 (Hormones) appears on 5,969 US grants and 6,594 published applications in this corpus.
Search patents in C07K- Granted patents
- 5,969
- Published applications
- 6,594
- Assignees
- 2,443
- Inventors
- 11,973
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 23 | 0 |
| 1977 | 30 | 0 |
| 1978 | 44 | 0 |
| 1979 | 22 | 0 |
| 1980 | 50 | 0 |
| 1981 | 22 | 0 |
| 1982 | 29 | 0 |
| 1983 | 45 | 0 |
| 1984 | 41 | 0 |
| 1985 | 49 | 0 |
| 1986 | 62 | 0 |
| 1987 | 79 | 0 |
| 1988 | 67 | 0 |
| 1989 | 69 | 0 |
| 1990 | 47 | 0 |
| 1991 | 88 | 0 |
| 1992 | 115 | 0 |
| 1993 | 91 | 0 |
| 1994 | 84 | 0 |
| 1995 | 109 | 0 |
| 1996 | 134 | 0 |
| 1997 | 188 | 0 |
| 1998 | 240 | 0 |
| 1999 | 187 | 0 |
| 2000 | 153 | 0 |
| 2001 | 158 | 41 |
| 2002 | 142 | 185 |
| 2003 | 109 | 309 |
| 2004 | 105 | 244 |
| 2005 | 92 | 248 |
| 2006 | 122 | 256 |
| 2007 | 117 | 185 |
| 2008 | 121 | 260 |
| 2009 | 138 | 279 |
| 2010 | 134 | 256 |
| 2011 | 154 | 266 |
| 2012 | 144 | 228 |
| 2013 | 171 | 252 |
| 2014 | 187 | 294 |
| 2015 | 207 | 286 |
| 2016 | 194 | 288 |
| 2017 | 191 | 264 |
| 2018 | 191 | 250 |
| 2019 | 197 | 300 |
| 2020 | 184 | 301 |
| 2021 | 186 | 251 |
| 2022 | 167 | 325 |
| 2023 | 132 | 269 |
| 2024 | 113 | 280 |
| 2025 | 149 | 263 |
| 2026 | 96 | 214 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07K 14/62Insulins1,003
- C07K 14/605Glucagons896
- C07K 14/61Growth hormone [gh], i.e. somatotropin849
- C07K 14/65Insulin-like growth factors, i.e. somatomedins449
- C07K 14/655Somatostatins409
- C07K 14/59Follicle-stimulating hormone [fsh]393
- C07K 14/57563Vasoactive intestinal peptide [vip]279
- C07K 14/635Parathyroid hormone, i.e. parathormone271
All 25 subgroupsShow fewer
- C07K 14/60Growth hormone-releasing factor [gh-rf], i.e. somatoliberin237
- C07K 14/5759Products of obesity genes226
- C07K 14/585Calcitonins226
- C07K 14/58Atrial natriuretic factor complex208
- C07K 14/64Relaxins106
- C07K 14/57545Neuropeptide y92
- C07K 14/57509Corticotropin releasing factor [crf]86
- C07K 14/57536Endothelin, vasoactive intestinal contractor [vic]80
- C07K 14/595Gastrins80
- C07K 14/57581Thymosin71
- C07K 14/645Secretins47
- C07K 14/66Thymopoietins42
- C07K 14/57527Calcitonin gene related peptide40
- C07K 14/57572Gastrin releasing peptide35
- C07K 14/57554Prolactin30
- C07K 14/63Motilins27
- C07K 14/57518Placental lactogen12
Recent patents
- Peptide used for immunotherapeutics29 Sep 2026US 12,747,276 B23H Bio. Co., Ltd.
- Nucleic acids encoding humanized anti-PACAP antibodies29 Sep 2026US 12,747,291 B2H. Lundbeck A.S.
- Selective MCL-1 binding peptides22 Sep 2026US 12,741,997 B2Massachusetts Institute of Technology
- Incretin analogs and uses thereof22 Sep 2026US 12,741,999 B2Eli Lilly and Company
- Insulin-Fc fusion proteins and methods of use to treat cancer22 Sep 2026US 12,742,000 B2Akston Biosciences Corporation
- Fgf21 compound / glp-1r agonist combinations with optimized activity ratio8 Oct 2026US 2026/0306587 A1Sanofi
- Fusion proteins of il-24 and immunostimulatory cytokines, nk cells expressing il-24 or fusion proteins, and methods of use thereof8 Oct 2026US 2026/0308218 A1Virginia Commonwealth University
- Stabilized analogues of calcitonin8 Oct 2026US 2026/0308222 A1Yissum Research Development Company of the Hebrew University of Jerusalem
- Method for genetically encoding 2-aminoisobutyric acid and its analogs and applications thereof8 Oct 2026US 2026/0308223 A1Edipro Pharmaceutical Technology Inc.
- Glucagon-like peptide-1 receptor agonist variants and methods thereof1 Oct 2026US 2026/0295054 A1
Most cited
By later US patents
- Non-immunogenic polypeptides2,007US 4,179,337 A1979
- Delivery of exogenous DNA sequences in a mammal1,218US 5,580,859 AVical Incorporated · 1996
- Induction of a protective immune response in a mammal by injecting a DNA sequence885US 5,589,466 AVical Incorporated · 1996
- Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants660US 5,750,373 AGenentech, Inc. · 1998
- In vivo introduction and expression of foreign genetic material in epithelial cells586US 4,980,286 AWhitehead Institute for Biomedical Research · 1990